Skip to main content

Table 4 Stratified prevalence of lifetime use of different CAM categories

From: Complementary and alternative medicine use in adults with autism spectrum disorder in Germany: results from a multi-center survey

 

Lifetime use in % (95% CI)

 

CAM category 1

CAM category 2

CAM category 3

CAM category 4

CAM category 5

Sex

     

 Male

26.5 (19.6–34.4)

25.9 (19.0–33.7)

15.7 (10.1–22.8)

15.0 (9.5–22.0)

2.9 (0.8–7.4)

 Female

28.2 (15.0–44.9)

14.3 (4.8–30.3)

25.0 (12.1–42.2)

16.7 (6.4–32.8)

5.7 (0.7–19.2)

Age groups (in years)

     

 18–24

31.6 (19.9–45.2)

23.2 (13.0–36.4)

10.7 (4.0–21.9)

14.3 (6.4–26.2)

0 (0.0–0.0)

 25–34

26.5 (16.5–38.6)

23.5 (14.1–35.4)

17.2 (8.9–28.7)

13.8 (6.5–24.7)

1.6 (0.0–8.8)

  ≥ 35

23.0 (13.2–35.5)

24.1 (13.9–37.2)

25.0 (14.4–38.4)

18.2 (9.1–30.9)

8.9 (3.0–19.6)

Diagnoses

     

 Other ASD diagnosis

29.5 (19.7–40.9)

27.0 (17.4–38.6)

18.3 (10.1–29.3)

19.7 (11.2–30.9)

3.0 (0.4–10.4)

 Asperger syndrome

25.0 (17.2–34.3)

21.3 (14.0–30.2)

17.1 (10.5–25.7)

12.4 (6.8–20.2)

3.8 (1.1–9.6)

Intellectual functioning

     

 IQ < 85

34.0 (21.5–48.3)

25.0 (13.6–39.6)

18.8 (8.9–32.6)

20.8 (10.5–35.0)

2.2 (0.1–11.8)

 IQ ≥ 85

23.8 (16.5–32.3)

19.8 (13.1–28.1)

16.9 (10.7–25.0)

12.7 (7.3–20.1)

3.4 (0.9–8.5)

Level of education

     

 Low

32.1 (19.9–46.3)

31.4 (19.1–45.9)

18.4 (8.8–32.0)

22.4 (11.8–36.6)

4.4 (0.5–15.2)

 Medium

26.5 (14.9–41.1)

24.5 (13.3–38.9)

15.2 (6.3–28.9)

17.0 (7.6–30.8)

4.3 (0.5–14.8)

 High

23.8 (15.1–34.4)

18.3 (10.6–28.4)

18.5 (10.8–28.7)

10.0 (4.4–18.8)

2.5 (0.3–8.7)

 Overall

26.9 (20.7–33.9)

23.6 (17.7–30.5)

17.6 (12.3–24.1)

15.3 (10.4–21.5)

3.5 (1.3–7.5)